47.73.Z - Retail sale of pharmaceutical products
47.91.Z - Intermediary retail sale, non-specialized
68.10.Z - Real estate activities on own account and development of building projects
68.31.Z - Real estate brokerage
69.20.Z - Accounting, bookkeeping and tax consultancy
73.12.D - Advertising through mass media
82.99.Z - Other business support activities, not elsewhere classified
86.90.A - Healthcare
86.90.D - Healthcare
86.90.E - Healthcare
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 3,4 | 5,3 | 2,9 | -44,6 |
EBITDA | 4 | 4,5 | 3,5 | -22,9 |
Short time liabilities | 10 | 8,7 | 9,8 | 13,2 |
Equity capital | 1,6 | 5 | 5,3 | 6,6 |
Operating profit (EBIT) | 3,5 | 4,1 | 2,9 | -28,3 |
Assets | 15,7 | 14,5 | 15,7 | 8,3 |
Net profit (loss) | 3,4 | 5,3 | 2,9 | -44,6 |
Cash | 3,4 | 1,7 | 4,2 | 145 |
Net income from sale | 68 | 69,9 | 78,9 | 12,8 |
Liabilities and provisions for liabilities | 14,1 | 9,5 | 10,4 | 9,2 |
Working assets | 11,3 | 10,6 | 14,1 | 33,7 |
Depreciation | 0,4 | 0,4 | 0,5 | 30 |
% | % | % | p.p. | |
Profitability of capital | 218 | 104,9 | 54,5 | -50,4 |
Equity capital to total assets | 9,9 | 34,5 | 33,9 | -0,6 |
Gross profit margin | 5 | 7,5 | 3,7 | -3,8 |
EBITDA Margin | 5,9 | 6,5 | 4,4 | -2,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 54 | 45 | 46 | 1 |
Current financial liquidity indicator | 0,1 | |||
Net dept to EBITDA | -1,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane